NCT06162039

Brief Summary

Registry analysis for prevalence of hemorrhagic myocardial infarction in the United States

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24,181

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 8, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

December 13, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2025

Completed
Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

1.3 years

First QC Date

November 30, 2023

Last Update Submit

September 2, 2025

Conditions

Acute Myocardial Infarction

Outcome Measures

Primary Outcomes (1)

  • Statewise proportion of Hemorrhagic Myocardial Infarction in the United States

    Prevalence of Hemorrhagic Myocardial Infarction

    10 years

Secondary Outcomes (3)

  • Statewise proportion of Acute Heart Failure in Hemorrhagic Myocardial Infarction

    30 days

  • Statewise proportion of re-hospitalization in Hemorrhagic Myocardial Infarction

    30 days

  • Statewise proportion of arrhythmia in Hemorrhagic Myocardial Infarction

    30 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All STEMI who underwent primary coronary intervention and revascularisation

You may qualify if:

  • Acute Myocardial Infarction - STEMI Primary PCI Availability of lab parameters and/or CMR

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Imaging Research Institute, Cardiovascular Imaging Research Center

Indianapolis, Indiana, 46202, United States

Location

Study Officials

  • Keyur P Vora, MD FACC

    Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Executive Director, Medical Imaging Research Institute

Study Record Dates

First Submitted

November 30, 2023

First Posted

December 8, 2023

Study Start

December 13, 2023

Primary Completion

March 15, 2025

Study Completion

March 15, 2025

Last Updated

September 8, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations

US(1)